Medicamen Organics Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Consistent revenue growth with a strong performance in the latest quarter, reflecting robust demand in the manufacturing sector.
Improved profit margins indicating effective cost management and operational efficiency over the past quarters.
Increased investment in R&D leading to innovative product offerings, positioning the company well for future growth.

NEGATIVES

Declining net profit in the latest quarter compared to previous quarters, raising concerns about profitability sustainability.
Higher raw material costs impacting margins, which may affect pricing strategies moving forward.
Increased competition in the manufacturing sector, putting pressure on market share and growth potential.

Field	Mar 24	Mar 25
Revenue	13.95	21.58
Expenses	11.62	17.72
Operating Profit	2.33	3.85
Other Income	0.01	0.05
Interest	0.36	0.29
Depreciation	0.36	0.37
Profit Before Tax	1.62	3.24
Tax	0.36	0.70
Net Profit	1.26	2.54
Eps in Rs	1.52	2.19